At Medi-Radiopharma, our journey began as a family vision and grew into a global mission. For 30 years, we have been at the forefront of nuclear medicine—developing and delivering radiopharmaceuticals that support accurate diagnostics and life-saving therapies in more than 70 countries worldwide.
Driven by quality, rooted in trust, and inspired by innovation, we believe that no patient should miss a treatment due to lack of access.
From sterile lyophilized drug products to cutting-edge theragnostic solutions, we continuously invest in technology, talent, and infrastructure to meet the rising global demand.
- We are proud of our people, our legacy, and our unwavering commitment to improving healthcare outcomes. Our long-term vision is simple: to grow with purpose, expand our capabilities, and ensure that nuclear medicine remains a pillar of modern healthcare.
Gergely Jánoki MSc. RPh, CEO.